BridgeMD
Compares treatment options for Postoperative Pain
Official title Interscalene Brachial Plexus Block Versus Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery
ClinicalTrials.gov ID: NCT07668648
What this study is testing
What is Bupivacaine?
Bupivacaine is an investigational medicine, being studied as a potential treatment for postoperative pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Arthroscopic shoulder surgery is associated with moderate to severe postoperative pain that may delay recovery and rehabilitation. Interscalene brachial plexus block (ISB) is widely used for postoperative analgesia in shoulder surgery; however, it may be associated with complications such as phrenic nerve paralysis.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Age between 18 and 75 years
- ASA physical status I, II, or III
- Scheduled for elective arthroscopic shoulder surgery under general anesthesia
- Provision of written informed consent
You likely can't join if
- Refusal to participate in the study
- Coagulopathy
- Current anticoagulant therapy
- Infection at the block site
- Previous surgery involving the planned block site
- Known allergy or history of toxicity to local anesthetics
See the full eligibility criteria
- Age between 18 and 75 years
- ASA physical status I, II, or III
- Scheduled for elective arthroscopic shoulder surgery under general anesthesia
- Provision of written informed consent
- Refusal to participate in the study
- Coagulopathy
- Current anticoagulant therapy
- Infection at the block site
- Previous surgery involving the planned block site
- Known allergy or history of toxicity to local anesthetics
- Hepatic failure
- Renal failure
- Uncontrolled diabetes mellitus
- Cognitive impairment or mental disability preventing reliable assessment
- Chronic opioid use or ongoing chronic pain treatment
- Pregnancy, suspected pregnancy, or breastfeeding
- Chronic pulmonary disease (e.g., COPD or asthma)
- Failed block
The study team makes the final eligibility decision.
Where it's taking place
- Bursa, Nilüfer, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bursa, Nilüfer, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.